Cargando…
Inhibition of FLT3 Expression by Green Tea Catechins in FLT3 Mutated-AML Cells
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by a block in differentiation and uncontrolled proliferation. FLT3 is a commonly mutated gene found in AML patients. In clinical trials, the presence of a FLT3-ITD mutation significantly correlates with an increased risk of relaps...
Autores principales: | Ly, Bui Thi Kim, Chi, Hoang Thanh, Yamagishi, Makoto, Kano, Yasuhiko, Hara, Yukihiko, Nakano, Kazumi, Sato, Yuko, Watanabe, Toshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688791/ https://www.ncbi.nlm.nih.gov/pubmed/23840454 http://dx.doi.org/10.1371/journal.pone.0066378 |
Ejemplares similares
-
ETV6/FLT3 Fusion Is a Novel Client Protein of Hsp90
por: Ly, Bui Thi Kim, et al.
Publicado: (2018) -
Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
por: Lam, Stephen S.Y., et al.
Publicado: (2020) -
UCB HCT in FLT3+ AML
por: Ustun, Celalettin, et al.
Publicado: (2017) -
Role of Biomarkers in FLT3 AML
por: Nitika,, et al.
Publicado: (2022) -
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML
por: Othman, Jad, et al.
Publicado: (2023)